Amneal Pharmaceuticals, Inc 10-Q for FY2023 Q3
Amneal Pharmaceuticals, Inc. (AMRX)
10-Q
2023-11-09
For: 2023-09-30
View Original
Added on
April 06, 2026
About this 10-Q
Amneal Pharmaceuticals, Inc filed this 10-Q on November 9, 2023, covering the quarter ended September 30, 2023 (FY2023 Q3).
Headline figures
Quarter ended September 30, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $620.04M
- up 13.7% from $545.56M a year earlier
- Net income
- $15.54M
- compared with a net loss of $7.61M a year earlier
- Diluted EPS
- $0.06
- compared with -$0.02 a year earlier